The owner-operator of a Tim Hortons in Woodstock, Ont., says installing blue lights in its washrooms has decreased the number of drug overdoses in the coffee shop. Some businesses have installed blue lights in their public washrooms in an effort to curb intravenous drug use there, working on the concept the lights reduce vein visibility. But …
Read More »Most toxic drug deaths are now from smoking. Advocates ask when B.C. will adjust to that reality
Last year, up to three quarters of people killed by B.C.’s toxic drug supply in parts of the province had smoked — not injected — their fatal dose, according to figures from the coroners service. But in some regions of B.C. that saw the highest rates of death by inhalation, …
Read More »A federal regulatory blunder could affect an unknown number of drug cases
Hundreds of drug cases before Canadian courts could be affected by a mistake made by the federal government when it updated Canada’s drug laws and legalized cannabis several years ago, CBC has learned. The government and police are downplaying the potential impact of the error. They maintain it has not …
Read More »B.C. will decriminalize up to 2.5 grams of hard drugs. Drug users say that threshold won’t decriminalize them
British Columbia is set to become the first province to decriminalize possession of small amounts of illicit drugs — but drug users, advocates, and the province’s chief coroner warn the threshold of 2.5 grams set by the federal government ignores the hard realities of how people buy and use drugs in …
Read More »Why decriminalizing drug possession won’t fix Canada’s toxic supply
This is an excerpt from Second Opinion, CBC Health’s weekly health and medical science newsletter. If you haven’t subscribed yet, you can do that by clicking here. Canada’s toxic drug supply problem can’t be fixed by decriminalizing the possession of small quantities of drugs alone — a move that advocates say is a …
Read More »‘Mass poisoning crisis’: Canadians need to change how we talk about drug deaths, advocates say
There’s a poisoning crisis gripping Canada, and it’s killing thousands of people each year. It doesn’t involve contaminated meat, lettuce or baby formula – the kinds of safety issues that prompt public concern, product recalls, and holding those responsible to account. It’s a vastly different response to Canada’s toxic drug …
Read More »Indian Pharma companies: Drug companies may take a hit, too
Indian pharmaceutical companies are staring at a possible write-off of their receivables from Sri Lanka, as they are struggling to repatriate money from the South Asian island country which is facing severe dollar crunch and a devaluation of local currency due to ongoing economic crisis. One of India’s leading drug …
Read More »namuscla: Lupin enters pact with Medis to distribute orphan drug in Europe
Drug maker Lupin on Wednesday said it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMuscla (mexiletine). Medis will commercialize NaMuscla for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders in Central and Eastern European countries. Under the agreement, Medis will initially …
Read More »Sputnik: Local drug companies find it hard to produce Sputnik’s second component
Indian drug manufacturers who have signed up with Russia’s RDIF to produce Sputnik V are struggling to scale up production of the second component of the Covid-19 vaccine, and are now counting on the approval for the single-shot Sputnik Light to salvage the situation, reports Viswanath Pilla. A top executive …
Read More »Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG, Health News, ET HealthWorld
Drug firm Mankind Pharma on Thursday said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19. 2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by …
Read More »